A detailed history of Tyro Capital Management LLC transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Tyro Capital Management LLC holds 1,754,976 shares of ROIV stock, worth $20.2 Million. This represents 10.39% of its overall portfolio holdings.

Number of Shares
1,754,976
Previous 1,744,327 0.61%
Holding current value
$20.2 Million
Previous $18.4 Billion 9.84%
% of portfolio
10.39%
Previous 8.36%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$10.17 - $12.5 $108,300 - $133,112
10,649 Added 0.61%
1,754,976 $20.3 Billion
Q2 2024

Aug 14, 2024

BUY
$10.36 - $11.74 $2.58 Million - $2.92 Million
248,733 Added 16.63%
1,744,327 $18.4 Billion
Q1 2024

May 15, 2024

BUY
$9.87 - $11.8 $1.48 Million - $1.77 Million
149,613 Added 11.12%
1,495,594 $15.8 Billion
Q4 2023

Feb 13, 2024

BUY
$8.38 - $11.58 $11.3 Million - $15.6 Million
1,345,981 New
1,345,981 $15.1 Billion

Others Institutions Holding ROIV

About Roivant Sciences Ltd.


  • Ticker ROIV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 704,382,976
  • Market Cap $8.09B
  • Description
  • Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...
More about ROIV
Track This Portfolio

Track Tyro Capital Management LLC Portfolio

Follow Tyro Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tyro Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tyro Capital Management LLC with notifications on news.